-
Multi-province announcement of quality unqualified drugs are mostly Chinese medicine Pfizer Atofalstin in the column
Time of Update: 2020-07-09
According to the official website of the State Drug Administration, since May, several provinces have issued notices for drug quality sampling of non-conforming drugs, according to insight database in
-
New research is helpful for early prevention and treatment of neuropathic pain
Time of Update: 2020-01-07
If the neuropathic pain is not treated in time, the development of chronic pain will have a greater impact on the quality of life of patients German researchers have reported that they have found a ne
-
Rao Yi founded this company to complete the round a financing of Huaxing capital group and Tencent leading investment
Time of Update: 2019-12-10
According to the latest news from Yigu, Beijing Yuanji Huayi Biotechnology Co., Ltd (hereinafter referred to as Yuanji Huayi) announced the completion of round a financing, which is led by Huaxing cap
-
Jiangxi: "4 + 7" expansion of varieties, drugs without evaluation will be purchased in quantity
Time of Update: 2019-11-27
According to yaozhi.com, on November 26, the people's Government of Jiangxi Province issued the implementation plan for the procurement and use of drugs with volume in Jiangxi Province The notice spec
-
Wuxi apptec launched the DNA coding compound library service package delay to accelerate the early discovery process of new drugs
Time of Update: 2019-09-04
September 4, 2019 / AP / -- Wuxi apptec today announced the launch of DNA coding compound library service package delay Through the leading DNA coding compound library technology (del for short), it p
-
[Zhou Jun] the "earthquake" hit the drug market; the issuance of drug "ID card" is imminent; with the deepening of anti-corruption, bribery will face the risk of "out of the game"; remote examination
Time of Update: 2019-07-08
This week's highlights: 1 The "earthquake" in the drug market, and the "alarm" of rational drug use by the drug administration; 2 Until you finally, the drug "ID card" will be issued soon; 3 The deepe
-
Qinghai Province announces the products for conformity assessment and application of generic drugs (the fourth batch
Time of Update: 2019-06-25
Qinghai pharmaceutical centralized purchase network publicized "through (deemed to pass) quality and efficacy consistency evaluation generic drugs (the fourth batch) declaration product publicity", th
-
21 drugs! Anti cancer drugs special record procurement publicity, Hengrui, Qilu, Zhengda Tianqing
Time of Update: 2019-03-15
On March 14, Zhejiang Province issued the announcement on the evaluation results of special record procurement of anticancer drugs According to the requirements of work plan for special centralized pr
-
85 proposals in the pharmaceutical industry suggest that you care
Time of Update: 2019-02-19
Up to now, a number of industry associations (schools) and enterprises, including China Pharmaceutical Enterprise Management Association, have submitted 85 proposals, covering nine major industry focu
-
Fluoxetine consistency evaluation: Shanghai Pharmaceutical ranked first in 6.7 billion market
Time of Update: 2018-08-15
On August 13th, Shanghai pharmaceutical announced that its holding subsidiary, Sinopharm, recently received the approval document for drug supplement application of Fluoxetine Hydrochloride Capsules (
-
Xu Haoyu of Yangtze River Pharmaceutical: quality should be kept in mind when Chinese medicine goes out
Time of Update: 2018-05-24
China China Pharmaceutical net China News May 9th China one belt, one road, Xu Haoyu, vice chairman of Yangzi Pharmaceutical Group, said in the "2018 China brand value evaluation information release a
-
Henan issued opinions to carry out the consistency evaluation of generic drugs in a scientific and standardized way
Time of Update: 2017-12-29
[policies and regulations of China Pharmaceutical network] in order to promote the evaluation of quality and efficacy consistency of generic drugs, Henan issued the implementation opinions on promotin
-
Antibody drug development capability test of local enterprises: Where is the main bottleneck? How competitive
Time of Update: 2017-08-22
Source: pharmaceutical economic report 2017-08-22 in the global scope, with the rapid development of biotechnology, the development direction of the pharmaceutical industry is gradually changing from
-
Suoyuan bio will start the international phase III clinical trials of antitumor drugs
Time of Update: 2017-02-17
[China Pharmaceutical network enterprise news] on February 15, Suoyuan biology, a leading medical enterprise, successfully discovered the biomarker dgm1 of the new antitumor drug db102, and plans to l
-
Challenges of similar supply chain model of pharmaceutical enterprises in hospital investment
Time of Update: 2016-11-16
Source: Murphy diaries 2016-11-16 pharmaceutical enterprises invested in hospitals in the form of PPP public-private partnership, hospital equity acquisition, hospital trusteeship, pharmacy trusteeshi
